[1] Gunther S,Fagone P,Jalce G,et al.Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets[J].Drug Discov Today,2019,24(2):428~439. [2] Su HT,Na N,Zhang XD,et al.The biological function and significance of CD74 in immune diseases[J]. Inflamm Res,2017,66(3):209~216. [3] Boor P.MIF in kidney diseases : a story of dr. jekyll and mr. hyde[J].Pathologe,2018, 39(2):177~184. [4] Bruchfeld A,Wendt M,Miller EJ.Macrophage migration inhibitory factor in clinical kidney disease[J].Front Immunol,2016,7:8. [5] Mangano K,Mazzon E,Basile MS,et al.Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach[J].Oncotarget,2018,9(25):17951~17970. [6] Joshua B,Shan S,Yousef A.A controversial cytokine: a review of structural features, callenges, and opportunities for drug development[J].Expert Opin Ther Targets,2016,20(12):1463~1475. [7] Li JH,Tang Y,Lv J,et al.Macrophage migration inhibitory factor promotes renal injury induced by ischemic reperfusion[J].Cell Mol Med,2019,23(6):3867~3877 [8] Liu Y,Zhang X,Liu G,et al.Expressions of macrophage migration inhibitory factor in patients with chronic kidney disease[J].Niger Clin Pract,2016,19(6):778~783. [9] L'Imperio V,Smith A,Ajello E,et al.MALDI-MSI pilot study highlights glomerular deposits of macrophage migration inhibitory factor as a possible indicator of response to therapy in membranous nephropathy[J].Proteomics Clin Appl,2019,13(3):e1800019 [10] 杨志,张骥,唐立萍.糖尿病肾病患者血浆中VCAM-1、MIF、SFRP-5含量与肾功能损害的相关性研究[J].海南医学院学报,2016,22(24):2974~2977. [11] Khalilpour J,Roshan-Milani S,Gharalari FH,et al. Macrophage migration inhibitory factor antagonist (p425) ameliorates kidney histopathological and functional changes in diabetic rats[J].Bras Nefrol,2019, 41(3):315~322. [12] Wang JP,Li YY,Chen YL,et al.Urinary macrophage migration inhibitory factor as a noninvasive biomarker in pediatric henoch-schnlein purpura nephritis[J].Clin Rheumatol,2017,230(5):258~261. [13] Hao J, Lv TG, Wang C, et al. Macrophage migration inhibitory factor contributes to anti-neutrophil cytoplasmic antibody-induced neutrophils activation[J].Hum Immunol,2016,77(12):1209~1214. [14] Magistroni R,Mangolini A,Guzzo S.et al.TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes[J].BMC Nephrol,2019, 20(1):355.
2021, Vol. 27 
冀公网安备13080202000677号